Effects of Goshajinkigan on Corneal Sensitivity, Superficial Punctate Keratopathy and Tear Secretion in Patients with Insulin-dependent Diabetes Mellitus
Authors:
- 1 January 2003
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 31 (01) , 103-109
Abstract
Goshajinkigan (Niu-che-shen-qi-wan in Chinese), a traditional herbal medicine, has been used in Japan to treat clinical symptoms of diabetic neuropathy. A double-masked study was performed to evaluate its effects on corneal sensitivity, superficial punctate keratopathy and tear production in patients with insulin-dependent diabetes mellitus. Fifty diabetic patients were randomized into two groups: Group A, in which 25 patients received Goshajinkigan orally, 7.5 g/day for 3 months; Group B, in which 25 patients were orally administered placebo, 6.0 g/day for 3 months; and in Group C, 25 non-diabetic subjects were orally administered Goshajinkigan, 7.5 g/day for 3 months. Corneal sensitivity was measured with an aesthesiometer. The area of superficial punctate keratopathy was expressed as a fluorescein staining score. Reflex tearing was determined with a Schirmer test without anesthesia. Goshajinkigan was analyzed by high-performance liquid chromatography. Corneal thresholds after treatment with Goshajinkigan (2.03 g/mm2) in Group A were significantly lower than those before treatment (2.47 g/mm2). Those in Groups B and C did not change after treatment. Fluorescein staining scores after administration of Goshajinkigan (0.64) in Group A were significantly lower than those before treatment (1.32). Those in Groups B and C did not change after treatment. Schirmer test results after Goshajinkigan administration (11.0 mm/5 min) in Group A were significantly higher than those before treatment (9.3 mm/5 min). Those in Groups B and C did not change after treatment. Hemoglobin A1c levels in Groups A, B,and C did not change after treatment. Several components in Goshajinkigan were found on high performance liquid chromatography. In conclusion, Goshajinkigan improved ocular surface disorders in patients with insulin-dependent diabetes mellitus.Keywords
This publication has 11 references indexed in Scilit:
- Tear secretion and tear film function in insulin dependent diabeticsBritish Journal of Ophthalmology, 2000
- Effect of Gosha-jinki-gan, a Kampo Medicine, on Enhanced Platelet Aggregation in Streptozotocin-Induced Diabetic RatsThe Japanese Journal of Pharmacology, 1998
- Improvement of Corneal Sensation and Tear Dynamics in Diabetic Patients by Oral Aldose Reductase Inhibitor, ONO-2235: A Preliminary StudyCornea, 1996
- Reversal of Abnormal Corneal Epithelial Cell Morphologic Characteristics and Reduced Corneal Sensitivity in Diabetic Patients by Aldose Reductase Inhibitor, CT-112American Journal of Ophthalmology, 1995
- The effects of Goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathyDiabetes Research and Clinical Practice, 1994
- Pharmacological effects of Gosha-jinki-gan-ryo extract: Effects on experimental diabetes.Folia Pharmacologica Japonica, 1992
- Schirmer Test After Topical Anesthesia and the Tear Meniscus Height in Normal EyesArchives of Ophthalmology (1950), 1979
- Factors Related to Corneal Epithelial Complications After Closed Vitrectomy in DiabeticsArchives of Ophthalmology (1950), 1979
- Neurotrophic Corneal Ulcers in Diabetes MellitusArchives of Ophthalmology (1950), 1977
- Corneal Sensitivity in DiabeticsArchives of Ophthalmology (1950), 1974